Antioxidants as a potential therapy against age-related neurodegenerative diseases: Amyloid beta toxicity and Alzheimer's disease

Current Pharmaceutical Design

Volumn 12, Issue 6, 2006, Pages 699-704

  Hajieva, P ^a   Behl, C ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Alzheimer's disease; Amyloid beta; Oxidative stress and ion chelators

Indexed keywords

3 NITROTYROSINE; ADVANCED GLYCATION END PRODUCT; AMYLOID BETA PROTEIN; ANTIOXIDANT; ASCORBIC ACID; CAROTENE; CATALASE; CLIOQUINOL; COPPER; EBSELEN; ESTROGEN; FLAVONOID; GLUTATHIONE PEROXIDASE; HYDROQUINONE DERIVATIVE; INDOLE DERIVATIVE; LIPOFUSCIN; LYCOPENE; METAL ION; PLACEBO; POLYPHENOL; POLYUNSATURATED FATTY ACID; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; RETINOL; SEROTONIN; STILBENE DERIVATIVE; SUPEROXIDE DISMUTASE; TOCOPHEROL; TYROSINE; UNINDEXED DRUG;

AGING; ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; BRAIN METABOLISM; DEGENERATIVE DISEASE; DISEASE COURSE; HUMAN; MEDICAL LITERATURE; MOUSE; NEUROCHEMISTRY; NEUROPATHOLOGY; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN INTERACTION; RAT; REVIEW; SENILE PLAQUE; VITAMIN SUPPLEMENTATION; ANIMAL; METABOLISM; PHYSIOLOGY;

AGING; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; ANTIOXIDANTS; HUMANS; NEURODEGENERATIVE DISEASES;

EID: 33645299343     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161206775474297     Document Type: Review

References (43)

1. Haass C, Schlossmacher MG, Hung AY, Vigo-Pelfrey C, Mellon A, Ostaszewski BL, et al. Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature 1992; 359(6393): 322-5.
2. Seubert P, Vigo-Pelfrey C, Esch F, Lee M, Dovey H, Davis D, et al. Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids. Nature 1992; 359(6393): 325-7.
3. Shoji M, Golde TE, Ghiso J, Cheung TT, Estus S, Shaffer LM, et al. Production of the Alzheimer amyloid beta protein by normal proteolytic processing. Science 1992; 258(5079): 126-9.
4. Selkoe D. Alzheimers Disease: Genes, Proteins, and Therapy. Physiol Rev 2001; 81: 741-766.
5. Stephenson DT, Rash K, Clemens JA. Amyloid precursor protein accumulates in regions of neurodegeneration following focal cerebral ischemia in the rat. Brain Res 1992; 593(1): 128-35.
6. Hugon J, Esclaire F, Lesort M, Kisby G, Spencer P. Toxic neuronal apoptosis and modifications of tau and APP gene and protein expressions. Drug Metab Rev 1999; 31(3): 635-47.
7. Shepherd CE, Bowes S, Parkinson D, Cambray-Deakin M, Pearson RC. Expression of amyloid precursor protein in human astrocytes in vitro: isoform-specific increases following heat shock. Neuroscience 2000; 99(2): 317-25.
8. Behl C, Davis JB, Lesley R, Schubert D. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 1994; 77(6): 817-27.
9. Tamagno E, Bardini P, Obbili A, Vitali A, Borghi R, Zaccheo D, et al. Oxidative stress increases expression and activity of BACE in NT2 neurons. Neurobiol Dis 2002; 10(3): 279-88.
10. Casley CS, Canevari L, Land JM, Clark JB, Sharpe MA. Beta-amyloid inhibits integrated mitochondrial respiration and key enzyme activities. J Neurochem 2002; 80(1): 91-100.
11. Anandatheerthavarada HK, Biswas G, Robin MA, Avadhani NG. Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells. J Cell Biol 2003; 161(1): 41-54.
12. Lustbader JW, Cirilli M, Lin C, Xu HW, Takuma K, Wang N, et al. ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science 2004; 304(5669): 448-52.
13. Atwood CS, Perry G, Zeng H, Kato Y, Jones WD, Ling KQ, et al. Copper mediates dityrosine cross-linking of Alzheimer's amyloid-beta. Biochemistry 2004; 43(2): 560-8.
14. Pogocki D and Schoneich C. Redox Properties of Met35 in Neurotoxic β-Amyloid Peptide. A Molecular Modeling Study. Chem. Res. Toxicol. 2002; 15, 408-418.
15. Huang X, Cuajungco MP, Atwood CS, Hartshorn MA, Tyndall JD, Hanson GR, et al. Cu(II) potentiation of Alzheimer Abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction. J Biol Chem 1999; 274(52): 37111-6.
16. Varadarajan S, Kanski J, Aksenova M, Lauderback C, Butterfield DA. Different mechanisms of oxidative stress and neurotoxicity for Alzheimer's A beta (1-42) and A beta (25-35). J Am Chem Soc 2001; 123(24): 5625-31.
17. Curtain CC, Ali F, Volitakis I, Cherny RA, Norton RS, Beyreuther K, Barrow CJ, et al. Alzheimer's disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits. J Biol Chem 2001; 276(23): 20466-73.
18. Schoneich C. Redox processes of methionine relevant to beta-amyloid oxidation and aging. Science 1992; 257: 1220-1224.
19. Pogocki D. Alzheimer's beta-amyloid peptide as a source of neurotoxic free radicals: the role of structural effects. Acta Neurobiol Exp (Wars) 2003; 63(2): 131-45.
20. Harman D. Prolongation of the normal life span by radiation protection chemicals. J Gerontol 1957; 12(3): 257-63.
21. Stadtman ER. Protein oxidation and aging. Science 1992; 257: 1220-24.
22. Tahara, S, Matsuo M, Kaneko T. Age-related changes in oxidative damage to lipids and DNA in rat skin. Mech Ageing Dev 2001; 122(4): 415-26.
23. Chevion M, Berenshtein E, Stadtman ER. Human studies related to protein oxidation: protein carbonyl content as a marker of damage. Free Radic Res 2000; 33 Suppl: S99-108.
24. Morawski M, Bruckner MK, Riederer P, Bruckner G, Arendt T. Perineuronal nets potentially protect against oxidative stress. Exp Neurol 2004; 188(2): 309-15.
25. Dei R, Takeda A, Niwa H, Li M, Nakagomi Y, Watanabe M, et al. Lipid peroxidation and advanced glycation end products in the brain in normal aging and in Alzheimer's disease. Acta Neuropathol (Berl) 2002; 104(2): 113-22.
26. Yan LJ, Levine RL, Sohal RS. Oxidative damage during aging targets mitochondrial aconitase. Proc Natl Acad Sci USA 1997; 94(21):11168-72.
27. Hensley K, Maidt ML, Yu Z, Sang H, Markesbery WR, Floyd RA. Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation. J Neurosci 1998; 18(20): 8126-32.
28. Leeuwenburgh C, Hansen PA, Holloszy JO, Heinecke JW. Oxidized amino acids in the urine of aging rats: potential markers for assessing oxidative stress in vivo. Am J Physiol 1999; 276(1 Pt 2): R128-35.
29. Stojanovic A, Roher AE, Ball MJ. Quantitative analysis of lipofuscin and neurofibrillary tangles in the hippocampal neurons of Alzheimer disease brains. Dementia 1994; 5(5): 229-33.
30. Ramamurthy B, Jones AD, Larsson L. Glutathione reverses early effects of glycation on myosin function. Am J Physiol Cell Physiol 2003; 285(2): C419-24.
31. Luth HJ, Ogunlade V, Kuhla B, Kientsch-Engel R, Stahl P, Webster J, et al. Age- and Stage-dependent Accumulation of Advanced Glycation End Products in Intracellular Deposits in Normal and Alzheimer's Disease Brains. Cereb Cortex 2005; 15(2): 211-20.
32. Pratico D, Sung S. Lipid peroxidation and oxidative imbalance: early functional events in Alzheimer's disease. J Alzheimers Dis 2004; 6(2): 171-5.
33. Ames BN. Micronutrients prevent cancer and delay aging. Toxicol Lett 1998; 102-103: 5-18.
34. Moosmann B, Behl C. Antioxidants as treatment for neurodegenerative disorders. Expert Opin Investig Drugs 2002; 11(10): 1407-35.
35. Behl C, Moosmann B. Oxidative nerve cell death in Alzheimer's disease and stroke: antioxidants as neuroprotective compounds. Biol Chem 2002; 383(34): 521-36.
36. Zandi PP, Anthony JC, Khachaturian AS, Stone SV, Gustafson D, Tschanz JT, et al. Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study. Arch Neurol 2004; 61(1): 82-8.
37. Cherny RA, Atwood CS, Xilinas ME, Gray DN, Jones WD, McLean CA, et al. Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron 2001; 30(3): 665-76.
38. Ritchie CW, Bush AI, Mackinnon A, Macfarlane S, Mastwyk M, MacGregor L, et al. Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. Arch Neurol 2003; 60(12): 1685-91.
39. Bayer TA, Schafer S, Simons A, Kemmling A, Kamer T, Tepest R, et al. Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Abeta production in APP23 transgenic mice. Proc Natl Acad Sci USA 2003; 100(24): 14187-92.
40. Atwood CS, Huang X, Khatri A, Scarpa, RC, Kim YS, Moir RD, et al. Copper catalyzed oxidation of Alzheimer Abeta. Cell Mol Biol (Noisy-le-grand) 2000; 46(4): 777-83.
41. Casetta I, Govoni V, Granieri E. Oxidative stress, antioxidants and neurodegenerative diseases. Curr Pharm Design 2005; 11(16): 2033-52.
42. Maksimenko AV. Experimental antioxidant biotherapy for protection of the vascular wall by modified forms of superoxide dismutase and catalase. Curr Pharm Design 2005; 11(16): 2007-16.
43. Vertuani S, Angusti A, Manfredini S. The antioxidants and proantioxidants network: an overview. Curr Pharm Design 2004; 10(14): 1677-94.